Bluebird stock soars on FDA committee news, despite overall market woes


Shares of bluebird bio Inc. rose substantially after a double endorsement by a key FDA advisory committee, despite overall market woes.

Previous Pennsylvania nurses to rally in Harrisburg to protest staffing, safety issues
Next Raleigh area restaurants that missed the mark on heath inspections